{
    "nctId": "NCT02562170",
    "briefTitle": "Protexa\u00ae Versus TiLoopBra\u00ae in Immediate Breast Reconstruction- A Pilot Study",
    "officialTitle": "Protexa\u00ae Versus TiLoopBra\u00ae in Immediate Breast Reconstruction- A Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Hereditary Breast and Ovarian Cancer Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "complications",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patients with indication for skin or nipple sparing mastectomy\n* BRCA1/2 mutation carriers with indication for skin or nipple sparing mastectomy\n\nExclusion Criteria:\n\n* prior local radiotherapy\n* inflammatory breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}